tradingkey.logo

Work Medical Technology Group Ltd

WOK
0.033USD
-0.016-32.92%
收盤 12/24, 13:00美東報價延遲15分鐘
4.79K總市值
--本益比TTM

Work Medical Technology Group Ltd

0.033
-0.016-32.92%

關於 Work Medical Technology Group Ltd 公司

Work Medical Technology Group Ltd is a holding company mainly engaged in the manufacturing of medical devices. The Company's main products include medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, guedel airways, and other Class I disposable medical devices, disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kit, oxygen face masks, anesthesia masks, laryngoscope blades, yankauer suction sets, nasal oxygen cannulas, and other Class II disposable medical devices, KN95 masks, filtering half mask, and other medical devices, as well as medical innovative devices and equipment, such as visualized prostatic dilatation catheter. The Company principally conducts its businesses in domestic and overseas markets, such as Asia, Africa, Europe, North America, South America, and Oceania.

Work Medical Technology Group Ltd簡介

公司代碼WOK
公司名稱Work Medical Technology Group Ltd
上市日期Aug 23, 2024
CEOWu (Shuang)
員工數量229
證券類型Ordinary Share
年結日Aug 23
公司地址Building 23, No. 2 Tonghuinan Rd., Xiaoshan District
城市HANGZHOU
上市交易所NASDAQ OMX - NASDAQ BASIC
國家China
郵編311200
電話8657182613568
網址https://www.workmedtech.com/
公司代碼WOK
上市日期Aug 23, 2024
CEOWu (Shuang)

Work Medical Technology Group Ltd公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Xiaoyang Li
Mr. Xiaoyang Li
Independent Director
Independent Director
--
--
Mr. Zhongxuan Li
Mr. Zhongxuan Li
Independent Director
Independent Director
--
--
Mr. Shuang Wu
Mr. Shuang Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Ningfang Liang
Mr. Ningfang Liang
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Baiming Yu
Mr. Baiming Yu
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Mr. Robert Johnson
Mr. Robert Johnson
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Xiaoyang Li
Mr. Xiaoyang Li
Independent Director
Independent Director
--
--
Mr. Zhongxuan Li
Mr. Zhongxuan Li
Independent Director
Independent Director
--
--
Mr. Shuang Wu
Mr. Shuang Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Ningfang Liang
Mr. Ningfang Liang
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Baiming Yu
Mr. Baiming Yu
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Mr. Robert Johnson
Mr. Robert Johnson
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2023
FY2022
FY2021
FY2020
業務USD
名稱
營收
佔比
Others
13.72M
0.00%
Medical devices other than masks
8.00M
58.95%
Marks
5.09M
37.53%
Commodity trading
325.43K
2.40%
地區USD
名稱
營收
佔比
China
12.60M
92.87%
Overseas market
967.69K
7.13%
業務
地區
業務USD
名稱
營收
佔比
Others
13.72M
0.00%
Medical devices other than masks
8.00M
58.95%
Marks
5.09M
37.53%
Commodity trading
325.43K
2.40%

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
LWY GROUP LTD
6.51%
Sabby Management, LLC
2.84%
Virtu Americas LLC
0.32%
Desjardins Securities Inc.
0.21%
Two Sigma Investments, LP
0.05%
其他
90.07%
持股股東
持股股東
佔比
LWY GROUP LTD
6.51%
Sabby Management, LLC
2.84%
Virtu Americas LLC
0.32%
Desjardins Securities Inc.
0.21%
Two Sigma Investments, LP
0.05%
其他
90.07%
股東類型
持股股東
佔比
Corporation
6.51%
Investment Advisor/Hedge Fund
2.84%
Research Firm
0.53%
Hedge Fund
0.07%
Venture Capital
0.04%
其他
90.01%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
9
79.91K
8.32%
+78.09K
2025Q2
8
6.35M
12.98%
-18.36K
2025Q1
8
6.35M
37.37%
-18.36K
2024Q4
14
12.62M
86.49%
+6.36M
2024Q3
10
12.51M
85.72%
+12.51M

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
LWY GROUP LTD
6.25M
6.51%
--
--
Feb 14, 2025
Virtu Americas LLC
--
0%
-40.01K
-100.00%
Mar 31, 2025
Two Sigma Investments, LP
--
0%
-11.39K
-100.00%
Jun 30, 2025
XTX Markets LLC
--
0%
-19.16K
-100.00%
Jun 30, 2025
Citadel Advisors LLC
29.65K
0.03%
-19.92K
-40.18%
Jun 30, 2025
UBS Financial Services, Inc.
52.41K
0.05%
+30.05K
+134.37%
Jun 30, 2025
HRT Financial LP
--
0%
-23.60K
-100.00%
Mar 31, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Oct 17, 2025
Merger
100→1
公告日期
類型
比率
Oct 17, 2025
Merger
100→1

常見問題

Work Medical Technology Group Ltd的前五大股東是誰?

Work Medical Technology Group Ltd的前五大股東如下:
LWY GROUP LTD
持有股份:6.25M
佔總股份比例:6.51%。
Virtu Americas LLC
持有股份:0.00
佔總股份比例:0.00%。
Two Sigma Investments, LP
持有股份:0.00
佔總股份比例:0.00%。
XTX Markets LLC
持有股份:0.00
佔總股份比例:0.00%。
Citadel Advisors LLC
持有股份:29.65K
佔總股份比例:0.03%。

Work Medical Technology Group Ltd的前三大股東類型是什麼?

Work Medical Technology Group Ltd 的前三大股東類型分別是:
LWY GROUP LTD
Sabby Management, LLC
Virtu Americas LLC

有多少機構持有Work Medical Technology Group Ltd(WOK)的股份?

截至2025Q3,共有9家機構持有Work Medical Technology Group Ltd的股份,合計持有的股份價值約為79.91K,占公司總股份的8.32% 。與2025Q2相比,機構持股有所增加,增幅為-4.66%。

哪個業務部門對Work Medical Technology Group Ltd的收入貢獻最大?

在FY2023,Others業務部門對Work Medical Technology Group Ltd的收入貢獻最大,創收13.72M,占總收入的--% 。
KeyAI